Pharming Group NV Sponsored ADR PHAR 深 沪
等待开盘 01-12 09:30:00 美东时间
18.71
+0.820
+4.58%
华盛通- 最 高18.82
- 今 开18.60
- 成交量 2.56万股
- 最 低 17.65
- 昨 收 17.89
- 总市值 13.04亿
- 52周最高 18.82
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 7.5018
- 委 比 -98.43%
- 总股本 6966.88万
- 历史最高 21.99
- 量 比 0.88
- 振 幅 6.54%
- 历史最低 6.10
- 每 手 1
- 风险率 3.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pharming Group reports preliminary 2025 revenues and announces Investor Day
Pharming Group N.V. reported preliminary 2025 revenues of approximately $376 million, exceeding expectations and reflecting strong demand for RUCONEST® and Joenja®. The company plans a virtual Investor Day on February 3, 2026, to discuss its advancing clinical pipeline, including leniolisib for immune dysregulation and KL1333 for mitochondrial diseases, alongside 2026 financial guidance. CEO Fabrice Chouraqui highlighted continued growth and stra...
01-08 06:00
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
2025-12-15 21:06
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
Pharming Group N.V. announced its participation in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025, in New York City. Anurag Relan, M.D., Chief Medical Officer of Pharming, will discuss the hereditary angioedema (HAE) market in a fireside chat at 1:50 pm ET / 19:50 CET. The company, dedicated to transforming lives of patients with rare diseases, is inviting one-on-one meetings with its management team. For more information, con...
2025-12-08 07:00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Kazia Therapeutics (NASDAQ:KZIA) shares increased by 51.6% to $8.73 du...
2025-11-19 20:05
Pharming Group shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
Pharming Group shares are trading higher after the company reported better-than...
2025-11-06 21:52
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Pharming Raises FY2025 Sales Guidance from $335.000M-$350.000M to $365.000M-$375.000M vs $339.625M Est
Pharming (NASDAQ:PHAR) raises FY2025 sales outlook from $335.000 million-$350.000 million to $365.000 million-$375.000 million vs $339.625 million estimate.
2025-11-06 16:19
Pharming Q3 EPS $0.10 Beats $(0.00) Estimate, Sales $97.300M Beat $93.430M Estimate
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.00) by 10100 percent. This is a 600 percent increase over losses of $(0.02) per share from the same
2025-11-06 14:07
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
NASHVILLE, Tenn., Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 202...
2025-10-29 04:05
Pharos Energy Executives Increase Shareholdings, Signaling Confidence
An announcement from Pharos Energy ( ($GB:PHAR) ) is now available. Pharos Ener...
2025-10-28 15:33
